Advertisement

Imaging Findings in Melanoma

  • Roxani D. Efthymiadou
Chapter

Abstract

Cutaneous melanoma is the most serious type of skin cancer. Its incidence has increased rapidly during the past few decades probably due to the increased ultraviolet radiation exposure but also to the earlier and more accurate diagnosis. Melanoma is an aggressive disease which may spread almost to any organ of the body. It has been well established that early detection and accurate staging are of critical value for the appropriate treatment and patient’s prognosis. Unfortunately, in many cases the lesions are detected late. The most common metastatic sides are the lungs, the liver, and central nervous system (CNS) [1].

References

  1. 1.
    King DM (2004) Imaging of metastatic melanoma. J HK Coll Radiol 7:66–69Google Scholar
  2. 2.
    Meyers MO, Yeh JJ, Frank J et al (2009) Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging. Ann Surg Oncol 16(4):941CrossRefGoogle Scholar
  3. 3.
    Mohr P, Eggermont AM, Hauschild A et al (2009) Staging of cutaneous melanoma. Ann Oncol 20(suppl 6):vi14–vi21CrossRefGoogle Scholar
  4. 4.
    Fishman EK, Kuhlman JE, Schuchter LM et al (1990) CT of malignant melanoma in the chest, abdomen, and musculoskeletal system. Radiographics 10(4):603CrossRefGoogle Scholar
  5. 5.
    Escott EJ (2001) A variety of appearances of malignant melanoma in the head: a review. Radiographics 21:625–639CrossRefGoogle Scholar
  6. 6.
    Voit C, Van Akkooi AC, Schäfer-Hesterberg G et al (2010) Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol 28(5):847CrossRefGoogle Scholar
  7. 7.
    Pfannenberg C, Aschoff P, Schanz S et al (2007) Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43(3):557CrossRefGoogle Scholar
  8. 8.
    Strobel K, Dummer R, Husarik DB et al (2007) High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology 244(2):566CrossRefGoogle Scholar
  9. 9.
    Reinhardt MJ, Joe AY, Jaeger U, Huber A et al (2006) Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 24(7):1178CrossRefGoogle Scholar
  10. 10.
    Jiménez-Requena F, Delgado-Bolton RC, Fernández- Pérez C et al (2010) Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma. Eur J Nucl Med Mol Imaging 37(2):284CrossRefGoogle Scholar
  11. 11.
    National comprehensive cancer care network. Clinical practice guidelines in oncology – v.2.2014: MelanomaGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.CT, MRI and PET-CT DepartmentHygeia HospitalNea Ionia, AttikiGreece

Personalised recommendations